Early and delayed preconditioning: differential mechanisms and additive protection

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Cellular Biology

Background:

• Ischemia-reperfusion (I/R) injury is a significant cause of cardiac damage.
• Endotoxin (ETX), adenosine (Ado), and phenylephrine (PE) are known to modulate cardiac protection.
• Understanding the interplay between early and delayed protective mechanisms is crucial for optimizing therapeutic strategies.

Purpose of the Study:

• To investigate if 24-h endotoxin (ETX) pretreatment induces delayed myocardial protection against I/R.
• To determine if acute adenosine (Ado) or phenylephrine (PE) pretreatment offers similar protection.
• To assess if Ado- and PE-induced protection mechanisms are preserved after endotoxemia.
• To evaluate if combining Ado/PE with ETX protection optimizes cardiac outcomes.
• To ascertain if these protective strategies depend on de novo protein synthesis.

Main Methods:

• Rat models were used to study myocardial protection.
• ETX or vehicle pretreatment was administered 24 hours prior to I/R.
• Acute pretreatment with Ado or PE was applied before I/R.
• Protein synthesis inhibition was employed using cycloheximide.
• Cardiac function (developed pressure, coronary flow, compliance) and creatine kinase leak were measured.

Main Results:

• Ado, PE, and ETX independently conferred myocardial functional protection.
• Acute Ado or PE pretreatment enhanced the protective effects of ETX.
• Cycloheximide abolished the delayed protection induced by ETX but not the acute protection by Ado or PE.

Conclusions:

• Early and delayed myocardial protection strategies can be combined to optimize cardiac protection.
• Delayed protection relies on de novo protein synthesis, while acute protection does not.
• These findings offer insights into novel therapeutic approaches for preventing I/R injury.